Valerio Therapeutics SA ALVIOP.TU
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Valerio Therapeutics SA Stock Halal?
Shariah Compliance Analysis of ALVIOP.TU Stock
United Kingdom Health Care Small Cap No. As of September 2026, Valerio Therapeutics SA (ALVIOP.TU) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Valerio Therapeutics SA does not pass Musaffa's business and financial screening criteria.
Valerio Therapeutics SA is a is a clinical-stage biotechnology company, which engages in the development of oncology drugs targeting tumor intracellular processes. The firm targets tumor DNA functions through unparalleled mechanisms of action in the sought-after field of DNA damage response (DDR). The company aims at holding a portfolio of advanced programs targeting severe pathologies with unmet clinical needs. The company has two programs in clinical development stage: Livatag, a doxorubicin Transdrag in Phase III, for the treatment of primary liver cancer, and Validive, a clonidine Lauriad in Phase II, for treatment of radio/chemo-induced severe oral mucositis at patients with head and neck cancer. The company also has one registered product in the United States, Beleodaq/ belinostat, for the treatment of peripheral T-Cell lymphoma (PTCL) and opportunities for further development; and two initial drugs registered in Europe and the United States: Loramyc/ Oravig for the treatment of oropharyngeal candidiasis, and Sitavig for the treatment of recurring herpes labialis.
ALVIOP.TU Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Valerio Therapeutics SA is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Valerio Therapeutics SA (ALVIOP.TU) Chart
Financial Metrics & Statements of Valerio Therapeutics SA (ALVIOP.TU)
FAQ's for Valerio Therapeutics SA (ALVIOP.TU)
- As of September 2026, Valerio Therapeutics SA ALVIOP.TU is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Valerio Therapeutics SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Valerio Therapeutics SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Valerio Therapeutics SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Valerio Therapeutics SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Valerio Therapeutics SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Valerio Therapeutics SA (ALVIOP.TU)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
